T cell receptor immunotherapy targeting NY-ESO-1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T cell receptor immunotherapy targeting NY-ESO-1, covering 2021-03-24 to 2021-03-24. Get the full timeline:
Most recent: Clinical Trial Update: T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer [Phase 2]